DrugPatentWatch Database Preview

Flibanserin - Generic Drug Details

« Back to Dashboard

What are the generic sources for flibanserin and what is the scope of patent protection?

Flibanserin is the generic ingredient in one branded drug marketed by Sprout Pharms and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Flibanserin has eighty-two patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for flibanserin

International Patents:	82
US Patents:	4
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	58
Clinical Trials:	19
Patent Applications:	939
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in flibanserin?	flibanserin excipients list
DailyMed Link:	flibanserin at DailyMed

Recent Clinical Trials for flibanserin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Andrew McDonald	Phase 2
Mohit Khera	Phase 2
Sprout Pharmaceuticals, Inc	Phase 2

See all flibanserin clinical trials

Pharmacology for flibanserin

Mechanism of Action

P-Glycoprotein Inhibitors

US Patents and Regulatory Information for flibanserin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes			Y	Y
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes

International Patents for flibanserin

Country	Patent Number	Estimated Expiration
Canada	2458067
New Zealand	532079
Austria	288911
Ecuador	SP044966
Hungary	228666
Denmark	1414816